Who we are and what we do?

Libang Capital (Canada) Limited and Libang Pharma Inc are the Canadian medical business subsidiaries of the Libang Pharmaceutical Group. We are a major pharmaceutical producer in China with extensive advanced technology development and manufacturing capabilities, and a national sales and distribution network throughout the public health system. We are also a health insurance service provider in China.

Libang Pharma Inc – Helping Canadians During the Covid19 Crisis

At present, Propofol is being used in unprecedented quantities globally and demand is increasing. As one of the world’s largest producers of propofol, Libang Pharma Inc is working with the federal and provincial governments, public health agencies and Group Purchase Organizations to guarantee supplies of this crucial drug during our current crisis.

Propofol is employed as an anaesthetic for surgical procedures and as a sedative during crucial symptomatic treatment therapies for Covid19 sufferers, especially for critical care patients undergoing machine-assisted ventilation treatment.

Our products are manufactured to the highest international standards, and we are currently in the process of obtaining a Health Canada license to import our propofol. If you would like to know more about our propofol manufacturing and supply capabilities, please do not hesitate to contact us.

Libang Capital (Canada) Ltd – Seeking and Developing New Health Technologies

North America is the world’s largest health market with numerous exceptional research institutions. Most of the companies in North American medical sector are small and medium-sized enterprises engaged in the research and development of innovative technologies, products and solutions. To succeed, these companies need investment and assistance to advance beyond the product development stage. Libang Capital (Canada) Limited can help North American companies succeed in North America and China. Located in Richmond, British Columbia, we provide one-stop service for pioneering entrepreneurs and enterprises. Through our Libang Group colleagues we can assist North American companies to develop, commercialize and sell their products to China.

Libang Capital (Canada) Limited wants to work with medical and health entrepreneurs with advanced medical technologies and a strategic interest in going to China. To help create future leaders in the life sciences, we can provide equity and market development expertise.